MedTrace Logo

Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

NCT03803293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11098

Last updated 2021-10-07

No results posted yet for this study

Summary

This study is being done to better understand how genetic information related to drug dosing and use can affect medical care of patients. By doing this study, the investigators are developing and improving ways to incorporate information about drug related genetic variants into the medical record.

Conditions

  • Healthy Subjects

Interventions

DIAGNOSTIC_TEST

Pharmacogenomic testing

A comprehensive PGx interpretive report created by OneOme (www.oneome.com) provides information on how an individual patient's genes may affect medication response. OneOme utilizes algorithms and curated clinical PGx knowledge to generate a highly intuitive personalized report based on a patient's genomic results.

Sponsors & Collaborators

Principal Investigators

  • Suzette Bielinski, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-13
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03803293 on ClinicalTrials.gov